Barchart is a leading provider of market data and services to the global financial, media, and commodity industries. From our interactive charting library, through to our leading financial analysis desktops, we connect you to the content you need.
| Period | Period Low | Period High | Performance | |
|---|---|---|---|---|
| 1-Month | 95.82 +1.94% on 11/06/24 | | 100.47 -2.78% on 10/24/24 | -0.56 (-0.57%) since 10/18/24 |
| 3-Month | 93.21 +4.80% on 09/10/24 | | 105.12 -7.08% on 10/01/24 | +1.97 (+2.06%) since 08/16/24 |
| 52-Week | 93.02 +5.01% on 08/05/24 | | 107.24 -8.91% on 05/20/24 | -4.24 (-4.16%) since 11/17/23 |
Third-quarter results from retail giants Walmart WMT and Target TGT will be a highlight of this week’s earnings lineup. Both omnichannel retailers are expected to post sound quarterly growth with...
ParaZero's SafeAir parachute systems gain EASA approval, enhancing drone operational safety and capabilities across Europe.Quiver AI SummaryParaZero Technologies Ltd. announced that its SafeAir M-300 Pro...
AmpliTech Group secures a $1M order for LNB products from a Fortune 1000 company, enhancing their market position.Quiver AI SummaryAmpliTech Group, Inc. has announced the receipt of an initial purchase...
Nuvini Group Limited appoints Aaron Ross as non-voting board adviser to enhance sales strategies and revenue growth.Quiver AI SummaryNvni Group Limited (Nuvini), a prominent acquirer of private SaaS B2B...
Cassava Sciences appoints Freda Nassif as Chief Commercial Officer, enhancing its strategy ahead of Phase 3 trial results for Alzheimer's treatment.Quiver AI SummaryCassava Sciences has appointed Freda...
Celularity Inc. resolved its Nasdaq compliance issue, ensuring continued listing after curing filing delinquencies.Quiver AI SummaryCelularity Inc. announced that its hearing regarding non-compliance with...
Artelo Biosciences will present innovative drug development data at the Cannabinoid-Derived Drug Development Summit in Boston.Quiver AI SummaryArtelo Biosciences, Inc. announced that Professor Saoirse...
ALLO-329 shows promise in treating autoimmune diseases by targeting CD19+ B cells and CD70+ T cells without lymphodepletion.Quiver AI SummaryAllogene Therapeutics has announced promising preclinical data...
Vaccinex reports promising Alzheimer’s treatment results, financial updates, and plans for partnerships to enhance development.Quiver AI SummaryVaccinex, Inc. has reported its financial results for the...
Draganfly Inc. announced a $3.76 million securities offering to fund corporate growth and product development efforts.Quiver AI SummaryDraganfly Inc. has announced a securities purchase agreement with...
The Barchart Trading Guide is a Sell Signal with a Soft Signal Strength.
| Symbol | Last | Change |
|---|---|---|
| AHZ24 | 97.68s | +1.58 |
| Bloom Commodity Index | ||
| ESZ24 | 5,918.25 | -1.75 |
| S&P 500 E-Mini | ||
| NQZ24 | 20,627.25 | -6.25 |
| Nasdaq 100 E-Mini | ||
| YMZ24 | 43,519 | -21 |
| Dow Futures Mini | ||
| QRZ24 | 2,319.10 | +1.40 |
| Russell 2000 E-Mini | ||
| EWZ24 | 3,228.40 | +0.70 |
| S&P Midcap E-Mini | ||
| ETZ24 | 5,918.25 | -1.75 |
| S&P 500 Micro | ||
| NMZ24 | 20,627.25 | -6.25 |
| Nasdaq 100 Micro | ||
| VIZ24 | 15.8900 | +0.0383 |
| S&P 500 VIX | ||
| GDZ24 | 537.75s | +11.00 |
| S&P GSCI | ||
| 3rd Resistance Point | 99.16 |
| 2nd Resistance Point | 98.47 |
| 1st Resistance Point | 98.08 |
| Last Price | 97.68s |
| 1st Support Level | 97.00 |
| 2nd Support Level | 96.31 |
| 3rd Support Level | 95.92 |
| 52-Week High | 107.24 |
| Fibonacci 61.8% | 101.81 |
| Fibonacci 50% | 100.13 |
| Fibonacci 38.2% | 98.45 |
| Last Price | 97.68s |
| 52-Week Low | 93.02 |
